Table 4 Prevalence of comorbidities among the "most costly" patients compared to the remainder.
From: Determinants of elevated healthcare utilization in patients with COPD
Comorbidity condition (ICD-9 codes) | Prevalence | Â | Â | ||
|---|---|---|---|---|---|
|  | "Most costly"* (n = 98) | The remainder (n = 291) | P value†| OR | 95% CI |
Hypertension (401 - 405) | 74% | 54% | <0.001 | 2.53 | 1.5 - 4.2 |
Myocardial infarct (410, 411) | 70% | 29% | <0.001 | 5.96 | 3.6 - 9.9 |
Connective tissue disease (710, 714, 725) | 58% | 57% | 0.89 | 1.03 | 0.6 - 1.6 |
Congestive heart failure (398, 402, 428) | 52% | 14% | <0.001 | 6.81 | 4.1 - 11.4 |
Diabetes Mellitus (250) | 50% | 24% | <0.001 | 3.10 | 1.9 - 5.0 |
Moderate and severe renal disease (403, 404, 580 - 586) | 37% | 20% | 0.001 | 2.38 | 1.4 - 3.9 |
Hemiplegia (342, 434, 436, 437) | 29% | 13% | <0.001 | 2.66 | 1.5 - 4.6 |
Peripheral vascular disease (440 - 447) | 24% | 13% | 0.01 | 2.09 | 1.2 - 3.7 |
Cerebrovascular disease (430 - 433, 435) | 23% | 12% | 0.01 | 2.17 | 1.2 - 3.9 |
Depression/Anxiety (296.2, 296.3, 311) | 23% | 15% | 0.06 | 1.72 | 1.0 - 3.0 |
Peptic ulcer (531 - 534) | 22% | 15% | 0.08 | 1.67 | 0.9 - 3.0 |
Diabetes Mellitus with organ damage (250.4 - 250.7) | 21% | 9% | 0.001 | 2.78 | 1.5 - 5.2 |
Pulmonary hypertension (415, 416) | 20% | 7% | <0.001 | 3.67 | 1.9 - 7.2 |
Any tumor (140 - 195) | 17% | 10% | 0.05 | 1.90 | 1.0 - 3.6 |
Obstructive sleep apnea (780.51, 780.53) | 16% | 9% | 0.06 | 1.89 | 1.0 - 3.7 |
Mild liver disease (571, 573) | 8% | 3% | 0.02 | 3.14 | 1.1 - 8.6 |
Moderate or severe liver disease (070, 570, 572) | 7% | 2% | 0.01 | 4.40 | 1.4 - 14.2 |
Dementia (290, 291, 294) | 3% | 2% | 0.42 | 1.81 | 0.4 - 7.7 |
Lymphoma (200, 202, 203) | 1% | 0% | 0.42 | 2.99 | 0.2 - 48.4 |
Metastatic solid tumor (196 - 199) | 1% | 2% | 0.63 | 0.59 | 0.1 - 5.1 |
Leukemia (204-208) | 1% | 1% | 0.74 | 1.49 | 0.1-16.7 |